“…It has also been suggested that the increase in the number of deaths due to asthma may be associated with the more frequent use of isoprenaline inhalers Speizer, Doll, Heaf & Strang, 1968). A new potent bronchodilator, salbutamol, has been recently introduced (Brittain, Farmer, Jack, Martin & Simpson, 1968) which, it has been suggested, does not have a significant effect on the cardiovascular system and does not produce a fall in arterial oxygen tension (Palmer & Diament, 1969;Palmer, Legge, Hamilton & Diament, 1970).…”